Scope
The Lancet Microbe publishes clinically relevant microbes at all scales—from the nature of the microbe (eg, antimicrobial resistance genes/plasmids, virulence factors) to the microbiome, to pathology (including immunology) to population level effects (eg, outbreaks, epidemiology).
We also publish early phase clinical trials and other interventional studies where the outcomes are focused on the pathogen. The journal also continues in the The Lancet's tradition of being a strong advocate for and collaborator with the community we serve.
We publish a range of content types including Articles, Comment, Correspondence, Newsdesk, and Personal View.